ROTE WILLIAM E.
Insider CIK 1698262 · TVTX Senior Vice President, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 350 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 55,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 57,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 47,746 | $63.61 | $3.04M | 98,197 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 65,104 | $63.12 | $4.11M | 145,943 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 57,500 | $26.88 | $1.55M | 211,047 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 55,000 | $15.46 | $850.3K | 153,547 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 350 | $17.96 | $6.3K | 98,547 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 57,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 55,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 350 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 47,746 | $63.61 | $3.04M | 98,197 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 65,104 | $63.12 | $4.11M | 145,943 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 57,500 | $26.88 | $1.55M | 211,047 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 55,000 | $15.46 | $850.3K | 153,547 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 350 | $17.96 | $6.3K | 98,547 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 39,650 | — | $0 | 350 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 39,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 39,650 | $17.96 | $712.1K | 194,395 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 39,000 | $25.25 | $984.8K | 154,745 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 270 | $65.31 | $17.6K | 98,197 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,000 | $63.65 | $190.9K | 98,467 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 29,021 | $62.66 | $1.82M | 101,467 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 63,907 | $61.99 | $3.96M | 130,488 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 39,650 | — | $0 | 350 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 39,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 270 | $65.31 | $17.6K | 98,197 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,000 | $63.65 | $191.0K | 98,467 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 29,021 | $62.66 | $1.82M | 101,467 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 63,907 | $61.99 | $3.96M | 130,488 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 39,650 | $17.96 | $712.1K | 194,395 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 39,000 | $25.25 | $984.8K | 154,745 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-06 | 2,763 | $43.95 | $121.4K | 115,474 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 4,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-04 | 2026-05-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 118,237 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-22 | 2026-04-23 | 9,100 | $39.09 | $355.7K | 113,987 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-04-13 | 2026-04-15 | 14,000 | — | $0 | 123,087 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 12,446 | $32.87 | $409.1K | 109,087 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 53,570 | — | $0 | 53,570 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-01-31 | 2026-02-03 | 20,090 | — | $0 | 121,533 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-12-24 | 2025-12-29 | 60,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-12-24 | 2025-12-29 | 60,000 | $20.61 | $1.24M | 161,443 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-12-24 | 2025-12-29 | 60,000 | $40.10 | $2.41M | 101,443 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-05-05 | 2025-05-05 | 3,198 | $21.05 | $67.3K | 100,241 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 4,920 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 103,439 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-12 | 2025-02-12 | 5,200 | $23.53 | $122.4K | 98,519 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-10 | 2025-02-12 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-10 | 2025-02-12 | 8,000 | — | $0 | 103,719 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 8,951 | $19.78 | $177.1K | 95,719 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 58,000 | — | $0 | 58,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 21,500 | — | $0 | 104,670 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 2,437 | $19.46 | $47.4K | 83,170 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-09 | 4,387 | $11.52 | $50.5K | 84,455 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-09-05 | 2024-09-09 | 6,750 | — | $0 | 88,842 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 2,174 | $8.53 | $18.5K | 83,310 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 2,590 | $8.86 | $22.9K | 80,720 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 25,000 | — | $0 | 85,484 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 2,062 | $8.96 | $18.5K | 60,484 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-09-05 | 2023-09-05 | 1,815 | $14.71 | $26.7K | 61,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-08-31 | 2023-09-05 | 3,300 | — | $0 | 62,988 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-05-10 | 2023-05-12 | 825 | $16.59 | $13.7K | 59,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 2,590 | $22.25 | $57.6K | 60,036 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 6,750 | — | $0 | 6,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 54,500 | — | $0 | 54,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 20,250 | — | $0 | 62,626 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 2,062 | $21.50 | $44.3K | 42,376 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-12 | 813 | $21.52 | $17.5K | 43,672 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-12 | 750 | $21.93 | $16.4K | 44,485 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 39,360 | — | $0 | 39,360 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 9,840 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-31 | 2022-02-02 | 1,125 | $27.40 | $30.8K | 45,235 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 46,360 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 1,875 | $24.98 | $46.8K | 36,520 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 2,500 | $27.40 | $68.5K | 38,395 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-10 | 2022-01-12 | 5,000 | — | $0 | 40,895 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 1,407 | $17.12 | $24.1K | 35,731 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-08-13 | 2021-08-17 | 4,500 | — | $0 | 37,138 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 1,562 | $19.46 | $30.4K | 31,707 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 1,563 | $19.14 | $29.9K | 33,269 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-18 | 1,250 | $28.67 | $35.8K | 34,832 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-17 | 2021-02-18 | 1,250 | $27.35 | $34.2K | 36,082 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 2,250 | $31.58 | $71.1K | 37,332 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 2,250 | $31.41 | $70.7K | 39,582 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 1,125 | $28.91 | $32.5K | 37,332 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 2,500 | $28.91 | $72.3K | 38,457 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-05 | 4,500 | — | $0 | 41,832 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 2,500 | $30.75 | $76.9K | 40,957 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 1,125 | $30.75 | $34.6K | 43,457 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-31 | 2021-02-02 | 5,000 | — | $0 | 44,582 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 57,500 | — | $0 | 57,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-21 | 2021-01-25 | 15,000 | — | $0 | 39,582 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | S Sale | 2020-11-16 | 2020-11-17 | 2,500 | $23.96 | $59.9K | 24,086 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-11-13 | 2020-11-13 | 2,500 | $23.62 | $59.0K | 26,586 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 29,086 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 24,086 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 25,586 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 27,086 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 23,494 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 812 | $17.16 | $13.9K | 24,021 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 813 | $14.95 | $12.2K | 24,833 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-03-10 | 2020-03-12 | 3,250 | $14.87 | $48.3K | 25,646 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-03-05 | 2020-03-09 | 3,250 | — | $0 | 28,896 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-02-18 | 2020-02-19 | 1,250 | $16.55 | $20.7K | 25,646 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-02-14 | 2020-02-19 | 1,250 | $16.72 | $20.9K | 26,896 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 27,185 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-15 | 2019-05-16 | 812 | $17.76 | $14.4K | 18,185 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-14 | 2019-05-16 | 813 | $17.78 | $14.5K | 18,997 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 19,810 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-19 | 2019-02-20 | 1,250 | $21.52 | $26.9K | 13,810 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-15 | 2019-02-20 | 1,250 | $21.44 | $26.8K | 15,060 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-12 | 2019-02-13 | 992 | $21.50 | $21.3K | 16,007 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-11 | 2019-02-13 | 993 | $21.38 | $21.2K | 16,999 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 2,188 | $24.25 | $53.1K | 18,304 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 312 | $24.83 | $7.7K | 17,992 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 300 | $24.57 | $7.4K | 20,492 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 2,200 | $23.62 | $52.0K | 20,792 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-11-09 | 2018-11-14 | 5,000 | — | $0 | 22,992 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 6,500 | — | $0 | 6,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 39,000 | — | $0 | 39,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-10 | 2018-05-14 | 6,500 | — | $0 | 17,656 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-02-14 | 2018-02-16 | 1,034 | $21.50 | $22.2K | 11,156 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-02-08 | 2018-02-12 | 1,985 | — | $0 | 12,190 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-02-13 | 2017-02-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-02-13 | 2017-02-15 | 10,000 | — | $0 | 10,000 | SEC↗ |